In 2012–13, FMRAC completed a governance review, leading to a new working Board composed of the 13 registrars of the provincial and territorial medical regulatory authorities, which first met in February 2014. During this period, FMRAC addressed several key issues, including new federal regulations on medical cannabis, physician-assisted dying, practice improvement, physician health, prescribing of controlled substances, and the development of an integrated risk management system for regulators.